UBS Reiterates Buy on Apple (AAPL) Following Product Launch
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
UBS reiterated a Buy rating and $115.00 price target on Apple (NASDAQ: AAPL) following the company's New product announcements. The iPhone 7 and 7 Plus came as advertised. The 7 starts at $649 and the 7 Plus at $769 with a storage range of 32-256GB, doubling storage at all tiers including for the 6/6s. New Apple Watch hardware is heavy on fitness improvements, including water resistance for swimming and built-in GPS. There also is an Apple Watch Nike+ for running.
Analyst Steven Milunovich commented, "Although investors have come to expect great product leaps from Apple, the fact is that that technology mostly improves in gradual steps. Calling today's announcements incremental is not to denigrate them. Speculation was again correct, so there were few surprises. Nevertheless, the combination of iPhone 7 advances (camera, battery life, screen, wireless earbuds, stereo speakers, water proofing) and Apple Watch Series 2 sport capabilities keep offerings competitive until more differentiation arrives next year."
Shares of Apple closed at $108.36 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple (AAPL) PT Raised to $148 at Macquarie; Services Segment Remains 'Underappreciated and Misunderstood'
- Union Pacific (UNP) PT Raised to $102 at Stifel Following 4Q Report
- Apple files $1 billion lawsuit against chip supplier Qualcomm
Create E-mail Alert Related CategoriesAnalyst Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!